Liquid Biopsy Market Trends 2023–2028: Outlook, Value & Key Companies

Market Size, Growth Valuation (2023-30)

Liquid Biopsy Market is projected to grow at a CAGR of around 26% during the forecast period, i.e., 2023-28.

✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

View Full Report - https://www.marknteladvisors.com/research-library/global-liquid-biopsy-market.html

Liquid Biopsy Market Structure – Segmentation Geography

By Work Process

Sample Preparation
Library Preparation
Sequencing
Data Analysis

By Technology

PCR
- RT-PCR
- dPCR
- Multiplex PCR
- Others
NGS
FISH
Other Technologies

By Usage

RUO
Clinical

By Sample Type

Blood
Urine
Saliva
Cerebrospinal Fluid

Here, the Blood sample is estimated to dominate the market in the forecasting years.

By Products

Test /Services
Kits and Consumables
Instruments

By Circulating Biomarkers

Circulating Tumor Cells
Cell-free DNA
Circulating Cell-Free RNA
Exosomes and Extracellular Vesicles
Others

Amongst the above, Circulating Tumor Cells are expected to witness predominant growth during the forecast years.

By Disease Type

Lung Cancer
Breast Cancer
Prostate Cancer
Colorectal Cancer
Melanoma
Other Cancers
Non-Oncology Disorders

By Clinical Application

Treatment Monitoring
Prognosis and Recurrence Monitoring
Treatment Selection
Diagnosis and Screening

By Region

North America
South America
Europe
Middle East Africa
Asia-Pacific.

North America is anticipated to attain a significant market share during the forecasting period.

Key Growth Trends (2023-2028)

Global Health Organizations' Initiatives Toward Cancer Awareness - The government in various countries and global health organizations have undertaken several initiatives and started several schemes to spread awareness about cancer and its treatment. For Instance,

On 4 February 2022, the World Health Organization's (WHO) International Agency for Research of Cancer (IARC) launched the World Code Against Cancer Framework. This online platform will promote prevention globally develop Regional Codes to help fight the disease.

Likewise, the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides breast cancer screening diagnosis for uninsured and low-income patients in the US every year, initiated by the US Centers for Diseases and Prevention (CDC) in 1991.

Download Free Sample PDF - https://www.marknteladvisors.com/query/request-sample/global-liquid-biopsy-market.html

Research Methodology

MarkNtel Advisors employs a thorough and iterative research methodology to enhance accuracy in market estimates. Our process combines bottom-up and top-down approaches, focusing on data triangulation for validation. It includes defining research objectives, selecting representative samples, and collecting data through surveys and interviews. Post-collection, we analyze and validate the data using statistical tools, ensuring reliability. Finally, we forecast market trends through predictive modeling, compiling our insights into detailed reports with charts and strategic recommendations for informed decision-making.

Competitive Analysis Framework

The Liquid Biopsy industry is moderately fragmented, with key players focusing on technological advancements and strategic partnerships. A detailed competitive analysis helps businesses benchmark against industry leaders and identify growth opportunities.

Leading Liquid Biopsy Companies are:

Bio-Rad Laboratories
Biocept Inc
Abcodia Ltd
Chronix Biomedical
Epic Sciences Inc
Hoffmann-La Roche AG
Cynvenio Biosystems, Inc.
GUARDANT HEALTH, INC
Illumina, Inc.
NeoGenomics Laboratories, Inc.
Menarini Silicon Biosystems, Inc.
Qiagen N.V.
Thermo Fisher Scientific
Personal Genome Diagnostics, Inc.
Qiagen N.V.

? Looking for a Customized Market Research Report? Visit – https://www.marknteladvisors.com/query/request-customization/global-liquid-biopsy-market.html

(Need global, regional or country-specific data? We can tailor research to your exact requirements)

Key Questions Answered in This Report:

What is the current market size of Liquid Biopsy, and what growth rate is projected by 2028?
Which key trends are driving Liquid Biopsy market expansion in the next five years?
How does market segmentation impact industry dynamics?
Which geographic regions offer the highest growth potential?
What are the primary challenges hindering Liquid Biopsy industry growth?
How do regulatory policies influence market development?
What are the latest technological advancements impacting the sector?
Who are the leading Liquid Biopsy companies, and what are their market shares?
What strategies are top competitors adopting to maintain dominance?
What are the emerging niche segments with high growth potential?
How do macroeconomic factors affect market performance?
What are the investment opportunities for new entrants?
How does pricing strategy vary across different market segments?
What are the future innovation trends expected in this industry?

Other Report:

About Us – MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative quantitative research company, strive to deliver data to a substantial varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact:

MarkNtel Advisors

Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

Contact No: +91 8719999009

Email: sales@marknteladvisors.com